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INTRODUCTION
Placement of a vascular access is essential in patients who
receive maintenance hemodialysis (HD). National Kidney
Foundation-Dialysis Outcomes Quality Initiative Clinical
Practice Guidelines for Vascular Access recommend place-
ment of a permanent vascular access (arteriovenous fistulae
[AVF] or arteriovenous grafts [AVG]) before initiation of
maintenance HD to avoid the use of central venous catheters
(CVC) (1). This is because permanent accesses provide bet-
ter blood flow rates (2) and are associated with less compli-
cation than CVC (3-6). In addition, unplanned initiation of
HD is associated with poorer outcomes than planned initia-
tion (7). However, according to previous reports, roughly two
thirds of patients initiate HD with CVC (8-10), although the
use of permanent access increases over time (8), and a majori-
ty of patients go on unplanned HD at initiation (11-13). 
For prior placement and use of a permanent access at ini-
tiation of HD, time is required for patient education, selec-
tion of dialysis modality, selection of the access type, surgi-
cal creation and maturation of the access. In this context,
adequate time for predialysis care is essential. Previous stud-
ies have found that late referral to a nephrologist is a major
determinant for use of CVC at initiation (8, 9, 14, 15) and
is associated with poorer outcomes than early referral (7). We
also found that late referral increased the risk of cardiovas-
cular disease-related mortality in HD patients (16). There-
fore early referral is crucial for reducing the use of CVC and
unplanned initiation of HD and improving outcomes. 
Although there are a few reports of predialysis care and
initial pattern of HD in Korea (14, 15), they were data from
a single center. In addition, Asian data about the type of access
in use and mode of presentation (unplanned vs. planned) in
patients initiating HD are scarce. According to the database
of the end-stage renal disease registry committee in Korean
Society of Nephrology, the prevalence of end-stage renal dis-
ease (ESRD) is increasing rapidly, and the number of HD
patients accounts for three fourths of patients on dialysis ther-
apy (17). Thus we undertook a multi-center study to inves-
tigate the type of access, presentation mode of the first HD
and the significance of care by a nephrologist in initial pat-
tern of HD and 6 month-mortality.
MATERIALS AND METHODS
Study design and population
A retrospective, multi-center study was conducted of pati-
ents with ESRD starting maintenance HD between January
2006 and June 2007, at dialysis centers of 8 hospitals of the
Catholic University of Korea. The centers were located in 6
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Status of Initiating Pattern of Hemodialysis: A Multi-center Study
This study was to evaluate the status of initiating pattern of hemodialysis (HD). Five
hundred-three patients in 8 University Hospitals were included. Presentation mode
(planned vs. unplanned), and access type (central venous catheters  [CVC] vs. per-
manent access) at initiation of HD were evaluated, and the influence of predialysis
care on determining the mode of HD and access type was also assessed. Most
patients started unplanned HD (81.9%) and the most common initial access type
was CVC (86.3%). The main reason for unplanned HD and high rate of CVC use
was patient-related factors such as refusal of permanent access creation and fail-
ure to attend scheduled clinic appointments. Predialysis care was performed in
57.9% of patients and only 24.1% of these patients started planned HD and 18.9%
used permanent accesses initially. Only a minority of patients initiated planned HD
with permanent accesses in spite of predialysis care. To overcome this, efforts to
improve the quality of predialysis care are needed. 
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cities of 4 provinces; Seoul, Gyeonggi-do (Uijeongbu, Suwon,
and Bucheon), Incheon, and Daejeon. Patients undergoing
HD because of acute kidney injury were excluded. 
Five hundred-three patients started HD between the study
period. Most of patients were located in Seoul city (Seoul;
n=211, Uijeongbu; n=128, Suwon; n=58, Bucheon; n=45,
Incheon; n=23, and Daejeon; n=38). Demographic charac-
teristics are shown in Table 1. The most common cause of
renal failure was diabetes, and most of patients had co-mor-
bidities, such as hypertension and cardiovascular diseases.
The median estimated glomerular filtration rate (eGFR) at
initiation of HD was 6.6 mL/min/1.73 m2 (range, 1.2-47.1
mL/min/1.73 m2). Laboratory values at initiation of HD are
shown in Table 2. 
Definitions
In this study, predialysis care refers to outpatient care ren-
dered by a nephrologist in a dedicated clinic for chronic kid-
ney disease (CKD) for at least 3 months prior to starting
HD, which is consistent with our (16) and other reports (7,
12). Unplanned initiation of HD refers to starting HD with-
out prior placement of a permanent access, and planned ini-
tiation of HD refers to starting HD with prior placement of
a permanent access, regardless of whether the access is func-
tional. CVC refers to either tunneled cuffed catheter (TCC)
or non-cuffed catheter (NCC). Of reasons for using CVC ini-
tially, patient-related factors include no show, refusal of surgery,
and change in modality from peritoneal dialysis (PD) to HD.
No show refers to failure to attend scheduled clinic appoint-
ments for at least 3 months, refusal of surgery refers to refusal
to create a permanent access prior to start of HD, and change
in modality from PD to HD refers to switch of modality
from PD to HD in patients who were on PD before. Acute
need for dialysis was defined as unexpected need for dialysis
because of rapid loss of glomerular filtration rate (GFR) or
development of severe uremic complications, such as uremia,
pulmonary edema with hypoxia, hyperkalemia or metabolic
acidosis. As Lenz et al. (18) defined in their report, rapid GFR
loss refers to sudden drop in GFR that deviated from declin-
ing rate observed in preceding months. Poor maturation of
the access refers to immature access despite at least 8 weeks
of maturation. Physician-related factors include delay in refer-
ral to a surgeon and delay between referral and surgery. Delay
in referral to a surgeon is delay by a nephrologist, although
the patient has selected the modality of dialysis, and it refers
to more than 4 weeks of interval between selection of modali-
ty and referral to a surgeon by a nephrologist. As Mendelssohn
et al. (19) reported that the shortest average time from access
referral to creation was 16 days, delay between referral and
surgery was defined as more than 3 weeks of delay between
referral to a surgeon and access creation. Planning renal trans-
plantation refers to a schedule to receive renal transplanta-
tion within 3 months after start of HD.
Data collection
The following data were collected from patient medical
records; patient demographics, laboratory values at initia-
tion of HD, predialysis care, presentation mode of initial HD
(unplanned vs. planned), reasons for unplanned HD, type of
Patients (n)
Age* (yr) 59 (16-93)
Male (%) 268 (53.3)
Primary cause of renal failure (%)
Diabetes 261  (51.9)
Hypertension 93  (18.5)
Chronic glomerulonephritis  66 (13.1)
Chronic tubulointerstitial disease 10 (2.0)
Polycystic kidney disease 7 (1.4)
Others 66 (13.1)
Co-morbidities (%)
Hypertension 412 (81.9)
Cerebrovascular disease 59 (11.7)
Cardiac disease 91 (18.1)
Ischemic heart disease 43
Heart failure 28
Ischemic heart disease and heart failure 7
Others 13
Predialysis care (%)
Never seen or seen in a CKD clinic <3 months 212 (42.1)
Seen in a CKD clinic 3-11 months 95 (18.9)
Seen in a CKD clinic ≥12 months 196 (39.0)
Table 1. Patient characteristics (n=503)
*, Expressed as a mean value. 
CKD, chronic kidney disease. 
Mean±SD (range)
Hemoglobin (g/dL) 8.6±1.8 (3.5-16.2)
Hematocrit (%) 25.5±5.3 (10.1-51.6)
Urea nitrogen (mg/dL) 95.9±39.6 (17.6-26.5)
Creatinine (mg/dL) 8.7±4.3 (1.5-33.0)
Total protein (g/dL) 6.1±0.9 (3.4-4.3)
Albumin (g/dL) 3.3±0.6 (1.5-4.9)
Calcium (mg/dL) 7.7±1.0 (4.0-11.3)
Phosphate (mg/dL) 6.2±2.1 (1.4-15.0)
Uric acid (mg/dL) 8.3±2.5 (2.2-17.8)
Sodium (mEq/L) 136.6±5.4 (114.0-166.0)
Potassium (mEq/L) 5.0±1.1 (2.4-8.5)
Table 2. Laboratory values at initiation of HD (n=503)
Values are expressed as mean±SD. To convert hemoglobin in g/dL to
g/L, multiply by 10; urea nitrogen in mg/dL to mM/L, multiply by 0.357;
creatinine in mg/dL to μ M/L, multiply by 88.4; total protein in g/dL to g/
L, multiply by 10; albumin in g/dL to g/L, multiply by 10; calcium in mg/
dL to mM/L, multiply by 0.2495; phosphate in mg/dL to mM/L, multiply
by 0.3229; uric acid in mg/dL to μ M/L, multiply by 59.48; sodium in mEq/L
to mM/L, multiply by 1; potassium in mEq/L to mM/L, multiply by 1.
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access in use at initiation and at 6 months after the first HD,
reasons for using CVC initially, and deaths within 6 months.
eGFR was determined by serum creatinine concentration,
age, gender, and race using the abbreviated Modification of Diet
in Renal Disease formula (MDRD-GFR) (20). 
Statistical analysis
Continuous data were computed by median or mean±
standard deviation (SD) and were compared using indepen-
dent t-test. Categorical variables were compared using chi-
square test. Multivariate logistic regression analysis was used
to estimate independent predictors of deaths within 6 months
after initiating HD. Included variables were age, gender,
presence of diabetes and cardiac and cerebrovascular disease,
predialysis care, presentation mode of initial HD, and the
first access type in use. The estimated standard error of the
coefficient (B1) was used to establish confidence intervals
(CI) of odds ratio (OR). 
RESULTS
Unplanned initiation vs. planned initiation
Four hundred-twelve patients (81.9%) underwent unplann-
ed initiation of HD, while 91 patients (18.1%) underwent
planned initiation. Reasons for unplanned dialysis were col-
lected in 333 patients. The leading one was uremia (n=182,
54.7%), and the followings were pulmonary edema with
hypoxia (n=93, 27.9%), hyperkalemia (n=18, 5.4%), metabol-
ic acidosis (n=10, 3.0%), combined reasons (n=18, 5.4%),
and other reasons (n=12, 3.6%). The rate of planned HD in
each center is listed in Table 3. The rate differed between
centers, ranging from 4.4% to 42.9%. 
Type of vascular access at initiation of HD
At initiation of HD, only 69 patients (13.7%) were using
permanent accesses; 56 patients (11.1%) using AVF and 13
patients (2.6%) using AVG. Four hundred and thirty-four
patients (86.3%) were using CVC; 263 patients (52.3%)
using NCC and 171 patients (34.0%) using TCC. The rate
of initial use of permanent access is listed in Table 3. The
rate differed between centers, ranging from 4.4% to 40.0%. 
Of 91 patients who started planned HD with prior place-
ment of a permanent access, 22 patients (24.2%) used CVC
initially, and the mean interval between access placement
and CVC insertion was 3.4±3.9 weeks (range, 1-15 weeks).
In contrast, 69 patients (75.8%) used permanent accesses
initially, and the mean interval between access placement
and the first cannulation was 16.8±20.8 weeks (range, 2
weeks-30 months) (p<0.001). 
Alphabet A-H represents each dialysis center included in this study.
HD, hemodialysis.
Center A B C D E F G H p
Planned HD (%) 15.7 15.8 8.7 4.4 17.4 31.0 42.9 15.6 <0.001
Initial use of permanent access (%) 11.8 15.8 8.7 4.4 13.0 17.2 40.0 10.9 <0.001
Predialysis care of all patients (%) 59.5 52.6 39.1 53.3 69.6 60.3 68.6 56.3 0.379
Predialysis care of diabetic patients (%) 55.4 63.6 50.0 56.0 58.3 60.0 72.2 60.3 0.924
Table 3. Rate of planned HD, initial use of permanent access and predialysis care in each center
%
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Fig. 1. Rate of planned HD. The proportion of patients who start-
ed planned HD was higher in patients with predialysis care than
in patients without predialysis care (24.1% vs. 9.9%, p<0.001).
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Fig. 2. Type of vascular access in use at initiation of HD. Patients
who received predialysis care used more permanent accesses
than those who did not receive predialysis care (18.9% vs. 6.6%,
p<0.001) at initiation of HD. 
TCC, tunneled cuffed catheter; NCC, non-cuffed catheter; AVG,
arteriovenous grafts; AVF, arteriovenous fistulae. 
TCC
NCC
AVG
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Effect of predialysis care on presentation mode and 
initial access type
As shown in Table 1, patients who received predialysis
care were 291 (57.9%), and those who did not receive pre-
dialysis care were 212 (42.1%). Of patients with predialysis
care, 95 patients (32.6%) received less than 12 months of
predialysis care, and 196 patients (67.4%) received at least
12 months of care. Of patients without predialysis care, infor-
mation on previous medical care was collected in 192 patients.
Seventy-three patients (38.0%) were seen by primary care
physicians, 28 (14.6%) by endocrinologists, 13 (6.8%) by
cardiologists, 39 (20.3%) in other departments, and 39 (20.3
%) did not have any medical care before. Of patients with
diabetic nephropathy, 107 patients (41.0%) did not receive
predialysis care. Forty-five patients (42.1%) were seen by
primary care physicians, 25 (23.4%) by endocrinologists,
and 8 (7.5%) by cardiologists. The rate of predialysis care of
patients with diabetic nephropathy did not differ between
centers (Table 3). 
The proportion of patients who started planned HD was
higher in patients with predialysis care than in patients with-
out predialysis care (24.1% vs. 9.9%, p<0.001, Fig. 1). The
proportion of patients who used permanent accesses at initi-
ation of HD was higher in patients with predialysis care than
in patients without predialysis care (18.9% vs. 6.6%, p<0.001,
Fig. 2). Of patients with predialysis care (n=291), patients
who received 12 months or more of care tended to use more
permanent accesses than those who received less than 12
months of care, but there was no statistical difference (20.6%
vs. 14.7%, p=0.2, Fig. 3).
Comparison of CVC use between planned HD and
unplanned HD 
Reasons for CVC use differed by the presentation mode of
initial HD (Table 4). In patients with unplanned HD, the
three most common reasons for using CVC were patient-
related factors (55.1%), acute need for dialysis (26.0%), and
absence of predialysis care (12.9%). In contrast, in patients
Unplanned
HD
n=412
n (%)
Total
n=434
n (%)
Planned HD
n=22
n (%)
Patient-related factors 227 (55.1) 0 (0) 227 (52.3)
No show 47 0 47
Refusal of surgery 151 0 151
Change in modality from  29 0 29
PD to HD
Acute need of dialysis 107 (26.0) 5 (22.7) 112 (25.8)
Absence of predialysis care 53 (12.9) 2 (9.1) 55 (12.7)
Poor maturation of the access 0 (0) 5 (22.7) 5 (1.2)
Physician-related factors 17 (4.1) 10 (45.5) 27 (6.2)
Delay in referral to a surgeon 12 5 17
Delay between referral and surgery 5 5 10
Planning renal transplantation 6 (1.5) 0 (0) 6 (1.4)
Unknown 2 (0.5) 0 (0) 2 (0.5)
Table 4. Reasons for starting HD with CVC according to the pre-
sentation mode (n=434)
No show, failure to attend scheduled clinic appointments for at least 3
months; Refusal of surgery, refusal to create a permanent access prior
to start of HD; Change in modality from PD to HD, switch of modality
from PD to HD in patients who were on PD before; Acute need of dialy-
sis, unexpected need of dialysis because of rapid loss of GFR or devel-
opment of severe uremic complications, such as uremia, pulmonary
edema with hypoxia, hyperkalemia or metabolic acidosis; Rapid GFR
loss, sudden drop in GFR that deviated from declining rate observed
in preceding months; Poor maturation of the access, immature access
despite at least 8 weeks of maturation; Delay in referral to a surgeon,
more than 4 weeks of interval between selection of modality and refer-
ral to a surgeon by a nephrologist; Delay between referral and surgery,
at least 3 weeks of delay between referral to a surgeon and access cre-
ation; Planning renal transplantation, a schedule to receive renal trans-
plantation within 3 months after start of HD.
HD, hemodialysis; CVC, central venous catheter; PD, peritoneal dialysis.
OR p
95% CI
Lower Upper
Age (per year) 1.05 0.001 1.02 1.09
Diabetes 0.45 0.5 0.20 1.01
Cardiac disease 3.32 0.004 1.46 7.55
Cerebrovascular disease 4.51 0.002 1.75 11.60
Absence of predialysis care 1.50 0.3 0.69 3.28
Unplanned initiation 1.57 0.7 0.18 13.92
CVC use at initiation 0.66 0.7 0.06 6.10
Table 5. Multivariate logistic regression analysis of predictors
of deaths within 6 month after initiation of HD
%
100
80
60
40
20
0
<12 months ≥12 months
Fig. 3. Type of vascular access in use at initiation of HD accord-
ing to the duration of predialysis care. Patients who received 12
months or more of predialysis care tended to use more perma-
nent accesses than those who received less than 12 months of
predialysis care (20.6% vs. 14.7%, p=0.2).
TCC, tunneled cuffed catheter; NCC, non-cuffed catheter; AVG,
arteriovenous grafts; AVF, arteriovenous fistulae. 
TCC
NCC
AVG
AVF
HD, hemodialysis; OR, odds ratio; CI, confidence interval; CVC, central
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with planned HD, major reasons were physician-related fac-
tors (45.5%), acute need for dialysis (22.7%), and poor mat-
uration of the access (22.7%). Of physician-related factors
(n=10), 5 were delay in referral to a surgeon, and 5 were delay
between referral and surgery. 
Change in type of vascular access at 6 months after 
initiation of HD
Type of access in use at 6 months after initiation of HD
was assessed after excluding patients who were on PD (n=
57), who received renal transplantation (n=25), or who were
lost for follow-up (n=71). Of 350 patients, 252 patients
(72.0%) were using AVF, 54 (15.4%) using CVC, and 44
(12.6%) using AVG. 
Influence of initial access type and predialysis care on
deaths within 6 months 
Mortality rate within 6 months after initiation of HD was
10.5% (n=36), after excluding patients who were on PD
(n=57), received renal transplantation (n=25), or were lost
for follow-up (n=77). In the multivariate logistic regression
analysis, independent factors associated with deaths within
6 month were age (OR 1.05 per year, 95% CI 1.02-1.09)
and the presence of cardiac disease (OR 3.32, 95% CI 1.46-
7.55) and cerebrovascular disease (OR 4.51, 95% CI 1.75-
11.60) (Table 5). Neither the absence of predialysis care, un-
planned initiation, nor the initial CVC use was a risk factor
predicting deaths within 6 months. 
DISCUSSION
Our study shows the discrepancy between clinical practice
and recommendations by guidelines in initiation of mainte-
nance HD. Most patients initiated HD in an unplanned
manner, without prior creation of a permanent access, and
used CVC as their first access. More patients who received
at least 3 months of care by a nephrologist started HD in a
planned manner, with prior creation of a permanent access,
and more used a permanent access than those referred later.
Nevertheless, only a minority of patients with predialysis
care initiated planned HD with permanent accesses. This is
the first multi-center report of how patients prepare and
start HD in Asia including Korea, and it is not just a prob-
lem of a facility as it was conducted from a cohort of 8 hos-
pitals in 4 provinces. Furthermore, the results demonstrate
the clinical implication of predialysis care in preparing HD
in practice. 
Although the use of permanent access increases over time
(8), most patients use CVC at initiation of HD. Lenz et al.
(18) reported the incidence of initial CVC use to be 92.3%,
Astor et al. (10) and Stehman-Breen et al. (9) to be about
66%. In our cohort, the proportion of patients who started
HD in an unplanned manner (81.9%) and that of patients
who used CVC as their first access (86.3%) were both higher
than other reports (7, 9, 10). The higher frequency may be
explained by two reasons. One reason is the difference in pop-
ulation. While most studies excluded patients who were to
enter PD therapy and who were to receive or who previously
received renal transplantation, there were 82 patients (16.3%)
in those categories included in our study. We included patients
who changed to PD or renal transplantation because many
patients start HD without choosing their dialysis modality
in clinical practice. The second reason is that the definition
of planned initiation of HD differed from other reports. Loren-
zo et al. (7) defined planned initiation as more than 3 months
of care by a nephrologist before starting HD, and Marron et
al. (12) defined it as outpatient, scheduled initiation. Our
definition of planned initiation was starting HD with prior
placement of a permanent access, regardless of whether the
access is functional. This was because we considered the cre-
ation of a permanent access is the most crucial and difficult
step in planning and preparing HD. Other multiple reasons
may be attributable, such as center-specific guidelines, coex-
isting diseases, and hemodynamic status. However, even con-
sidering the difference, this higher rate reflects that our clini-
cal practice is far from what guidelines recommend, which
was consistent with other studies (7-13, 18, 21). 
As shown in Table 4, the most common reasons for CVC
use were patient-related factors. This shows that the patient’s
reluctance is the major barrier of access planning in our clin-
ical practice. Our result is different from results by Lenz et
al. (16), in which the most common reasons were inadequate
predialysis care. There are three explanations for the higher
proportion of patient-related factors than the absence of pre-
dialysis care in our results. First, the definition of patient-
related factors was less strict than that of other study (18).
In our study, no show was defined as failure to attend sched-
uled clinic appointments for at least 3 months, in contrast
other study (18) defined it as failure to attend at least half of
scheduled appointments. Second, ‘absence of predialysis care’
was judged to be responsible only when the patient had no
obvious reasons other than the absence of predialysis care.
Third, the proportion of patients who refused surgery for
vascular access was higher in our cohort than in the cohort
by Lenz et al. (18). In our result, refusal of surgery account-
ed for 34.8% of total CVC users (n=434). In contrast, in
the cohort by Lenz et al. (18), it accounted for only 1.9% of
total CVC users (n=157). 
The presence of predialysis care was an important factor
in determining both the mode of presentation and initial
access type. Thus early referral to a nephrologist is indeed
essential for increasing numbers of patients initiating planned
HD and using permanent accesses (8, 9, 11-15, 18, 22). How-
ever, there are two considerable aspects in our study. One is
the quality of predialysis care. It is remarkable that despite
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more than 3 months of care by a nephrologist, most patients
started unplanned HD (75.9%) and used CVC initially (81.1
%). In our study, the proportion of predialysis care was sim-
ilar between centers. But the rate of planned HD and use of
permanent access differed between centers, ranging from
4% to 43% (Table 3). This indicates that the quality of pre-
dialysis care differed between centers. Dialysis education by
nephrologists and HD nurses and frequent medical visits
can influence the timing and planning of HD (11, 12, 23),
and efforts of physicians for vein preservation and preopera-
tive vein mapping can influence the choice of access type
(24). Thus a multidisciplinary team-based care is suggested
to improve the quality of predialysis care, which incorporates
nephrologists, nurses, dieticians and social workers (19, 25,
26). Another aspect is the definition of early referral. As the
economical burden of the insurance system and concept of
dialysis differ between countries, the accurate time for early
referral is difficult to estimate. However, we should consider
factors that are out of our control, such as acute need for dial-
ysis, rapid GFR loss or poor maturation of the access, which
accounted a substantial portion of reasons for CVC use in
our study (Table 4). Buck et al. (11) reported that service-
related factors were responsible for urgent initiation of HD
among patients who had been seen by a nephrologist at least
4 months, including delayed discussion and counseling by
HD nurses and late referral for access creation. Lenz et al.
(18) found that there were patient-related factors, physician-
related factors and unexpected reasons for CVC use despite
at least 4 months of predialysis care. To overcome these prob-
lems, 3-4 months may be insufficient for adequate predialy-
sis care, and from our results, the optimal period for predial-
ysis care seems to be more than 3 months. Some authors sug-
gested it has to be at least 12 months (11, 27, 28). Although
a statistical significance was not achieved, patients with pre-
dialysis care at least 12 months tended to use more perma-
nent accesses at initiation than patients with predialysis care
less than 12 months in this study (Fig. 3). To determine the
adequate length of time for predialysis care, further study is
required.
The time of permanent access placement is also of impor-
tance in determining the access type at initiation. In our
study, about a quarter of patients who had prior access place-
ment used CVC as their first access, and the interval between
access placement and initial HD was significantly shorter in
CVC users than in permanent access users (3.4±3.9 weeks
vs. 16.8±20.8 weeks). This indicates that delay in creating
a permanent access was a significant contributor for CVC use
even in patients who had prior access placement. As shown
in Table 4, acute need for dialysis (22.7%), poor maturation
of the access (22.7%), delay in referral to a surgeon (22.7%)
and delay between referral and surgery (22.7%) accounted
most reasons for CVC use. In addition, of patients who did
not have prior access placement, one third used CVC because
of acute need for dialysis (26.0%), delay in referral to a sur-
geon (2.9%) and delay between referral and surgery (1.2%).
If delays in access creation had been reduced, the frequent
CVC use could have been reduced in 32.0% of the entire
CVC users. 
The encouraging part in our study is that, although a minor-
ity of patients used permanent accesses at their first HD,
most (84.6%) changed to permanent accesses after 6 months
and that AVF was the leading type in use (72%). This rate
is higher than that of United States or Canada (8, 19, 21,
29), but lower than those of several countries in Europe (21).
This indicates that a facility’s preference and approaches to
choice of access differ between countries and determine the
access type in use. Therefore efforts to meet the goal for CVC
use to <10% (1) can further increase the AVF use.
Contrary to our expectation, neither the absence of pre-
dialysis care, unplanned initiation, nor initial CVC use was
a risk predicting deaths within 6 months (Table 5). This result
differs from other reports which show the independent con-
tribution of care by a nephrologist (8, 22) and the type of
access (7, 10, 27, 30-32) in determining the patient outcome.
Our result can be explained by two reasons. First, the follow-
up period of 6 months may have been relatively short to assess
the long-term survival. If the follow-up period were extend-
ed longer, there may be difference in mortality between the
access types as other studies (7, 8, 15). Second, the overuse
and imprudent preference to CVC of nephrologists ourselves
may have made no difference in mortality rate.
In conclusion, most patients initiated unplanned HD and
used CVC initially, in spite of predialysis care. To reduce the
use of CVC in patients initiating HD, early referral for pre-
dialysis care, access planning, and timely attempts for cre-
ation of a permanent access is essential. 
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